From: Outcomes of autologous bone marrow mononuclear cells for cerebral palsy: an open label uncontrolled clinical trial
Adverse events
N (%)
Fever after transplantation
12 (30%)
Vomiting after transplantation
9 (22.5%)
Seizures after transplantation
0 (0%)
Other complications